A 'Bear Raid' in Affymax (AFFY)?; Shares Plunge
Tweet
Share
E-mail
Get Alerts AFFY Hot Sheet
Join SI Premium – FREE
Traders are chatting about the "bear raid" being seen in Affymax, Inc. (Nasdaq: AFFY) ahead of today's FDA decision on peginesatide, which in December an FDA panel backed 15 to 1.
Shares of AFFY are recovering off the lows, but still down 8.5%.
Shares of AFFY are recovering off the lows, but still down 8.5%.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hunterbrook bullish on Modine Manufacturing (MOD)
- Citigroup set to join top banks in Anthropic IPO - Bloomberg
- Two Binance Employees Detained In The U.A.E. Amid Police Inquiries - NYT
Create E-mail Alert Related Categories
FDA, Momentum Movers, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
